Please use this identifier to cite or link to this item: https://hdl.handle.net/10216/157905
Full metadata record
DC FieldValueLanguage
dc.creatorGonçalves, J
dc.creatorSantos, CD
dc.creatorFresco, P
dc.creatorFernandez-Llimos, F
dc.date.accessioned2024-08-11T23:07:04Z-
dc.date.available2024-08-11T23:07:04Z-
dc.date.issued2024
dc.identifier.issn0870-2551
dc.identifier.othersigarra:666087
dc.identifier.urihttps://hdl.handle.net/10216/157905-
dc.description.abstract[No abstract available]
dc.language.isoeng
dc.rightsopenAccess
dc.titleReply to: RAAS inhibitors in COVID-19: Not all are created equal. Telmisartan is the one
dc.typeOutra Publicação em Revista Científica Internacional
dc.contributor.uportoFaculdade de Farmácia
dc.identifier.doi10.1016/j.repc.2023.10.005
dc.identifier.authenticusP-00Z-V69
Appears in Collections:FFUP - Outra Publicação em Revista Científica Internacional

Files in This Item:
File Description SizeFormat 
666087.pdf271.09 kBAdobe PDFThumbnail
View/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.